Introduction ST-Elevation Myocardial Infarction (STEMI) accounted for 43.3% of Acute Coronary Syndromes (ACS) in Malaysia in 2019. Malaysia uses thrombolysis, specifically streptokinase, for acute ...

Introduction Thrombolytic therapy using streptokinase has been widely used for acute myocardial infarction to achieve recanalization in infarct related artery. Bleeding into critical organ and space ...

Although the benefits of thrombolytic therapy are well established in patients younger than age 75 years with acute ST-elevation myocardial infarction, the value of thrombolytic treatment in ...

OBJECTIVE To evaluate the prevalence of plaque erosion as a substrate for coronary thrombosis. DESIGN Pathological study in patients with acute myocardial infarction not treated with thrombolysis or ...

Unlike cerebral infarction, there is limited evidence to support the use of thrombolysis in SCI. This case report presents an 86‐year‐old male with multiple comorbidities who presented with ...

Box 2. Restratification of thrombolysis in myocardial infarction grade 5 thrombus. Angiographic detection of a grade 5 TIMI thrombus leads to further exploration of the occlusive thrombotic content.

inter.nl.net Objectives: To study the incidence and patient characteristics of aborted myocardial infarction in both prehospital and in-hospital thrombolysis. Design: Retrospective, controlled, ...

Compared with rivaroxaban, abelacimab is associated with fewer bleeding events in patients with AF and moderate to high risk for stroke.

Several iterations of the Thrombolysis In Cerebral Infarction (TICI) score, adapted from the Thrombolysis In Myocardial Infarction (TIMI) coronary circulation scoring system to the cerebral ...

Cardiac fibrosis plays an indispensable role in cardiac tissue homeostasis and repair after myocardial infarction (MI). The cardiac fibroblast-to-myofibroblast differentiation and extracellular matrix ...